Genpact Ownership
| G Stock | USD 48.42 0.78 1.64% |
Shares in Circulation | First Issued 2006-03-31 | Previous Quarter 180.9 M | Current Value 180.9 M | Avarage Shares Outstanding 192.7 M | Quarterly Volatility 53.6 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Genpact |
Genpact Stock Ownership Analysis
About 99.0% of the company shares are owned by institutional investors. The book value of Genpact was currently reported as 13.58. The company has Price/Earnings To Growth (PEG) ratio of 1.7. Genpact Limited last dividend was issued on the 9th of December 2024. Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. The company was founded in 1997 and is based in Hamilton, Bermuda. Genpact is traded on New York Stock Exchange in the United States. To learn more about Genpact Limited call Nallicheri Tyagarajan at (441) 298-3300 or check out https://www.genpact.com.Besides selling stocks to institutional investors, Genpact also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Genpact's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Genpact's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Genpact Quarterly Liabilities And Stockholders Equity |
|
Genpact Insider Trades History
Only 1.01% of Genpact Limited are currently held by insiders. Unlike Genpact's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Genpact's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Genpact's insider trades
Genpact Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Genpact is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genpact Limited backward and forwards among themselves. Genpact's institutional investor refers to the entity that pools money to purchase Genpact's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 3.6 M | Jpmorgan Chase & Co | 2024-09-30 | 3.1 M | Alliancebernstein L.p. | 2024-09-30 | 3 M | Citadel Advisors Llc | 2024-09-30 | 2.4 M | Capital Research & Mgmt Co - Division 3 | 2024-09-30 | 2.1 M | Norges Bank | 2024-06-30 | 2 M | Fuller & Thaler Asset Management Inc | 2024-09-30 | 2 M | Amvescap Plc. | 2024-09-30 | 1.8 M | Causeway Capital Management Llc | 2024-09-30 | 1.8 M | Fmr Inc | 2024-09-30 | 24.6 M | Blackrock Inc | 2024-09-30 | 18.2 M |
Genpact Limited Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Genpact insiders, such as employees or executives, is commonly permitted as long as it does not rely on Genpact's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Genpact insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Genpact's latest congressional trading
Congressional trading in companies like Genpact Limited, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Genpact by those in governmental positions are based on the same information available to the general public.
| 2024-09-18 | Representative Michael McCaul | Acquired Under $15K | Verify |
Genpact Outstanding Bonds
Genpact issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genpact Limited uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genpact bonds can be classified according to their maturity, which is the date when Genpact Limited has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Genpact Corporate Filings
| 28th of January 2025 Other Reports | ViewVerify | |
| 17th of January 2025 Other Reports | ViewVerify | |
F4 | 14th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Data Processing & Outsourced Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.156 | Dividend Share 0.595 | Earnings Share 3.64 | Revenue Per Share | Quarterly Revenue Growth 0.066 |
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.